Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Adverse drug events

Newborn pulmonary hypertension data provide reassurance to pregnant women taking SSRIs

Risk of persistent pulmonary hypertension in offspring of women taking SSRI antidepressants more modest than suggested in previous studies. In the image, a newborn child

Source: ChameleonsEye /

Babies exposed to SSRI antidepressants in utero may be at risk from persistent pulmonary hypertension

In 2006, the US Food and Drug Administration warned about an association between maternal use of selective serotonin reuptake inhibitors (SSRIs) in pregnancy and the risk of persistent pulmonary hypertension in the newborn (PPHN). The warning was based on a single epidemiological study that found a sixfold increased risk, yet subsequent studies have found no association or a much more modest risk increase.

A study involving 3.7 million pregnant women, published in JAMA[1] on 2 June 2015, showed that the risk of PPHN was modestly increased with maternal use of SSRI or non-SSRI antidepressants; however, the strength of associations fell with adjustment for confounders. “The absolute risk was small, and the risk increase appears more modest than suggested in previous studies,” the authors conclude. 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068697

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.